medigraphic.com
ISSN 0016-3813 (Print)

2018, Number S1

<< Back Next >>

Gac Med Mex 2018; 154 (S1)

Principios y modalidades en terapia de reemplazo renal continua

Chávez-Ińiguez JS, Cerdá J

Language: Spanish
References: 34
Page: 31-39
PDF size: 473.53 Kb.


ABSTRACT

Continuous renal replacement therapy (CRRT) is used in critically ill patients with acute kidney injury. This modality of treatment, loaded with a history full of passion and ambition, has revolutionized treatment in intensive care units. Technological advances allow the removal of toxins and management of fluids and molecules in a gradual and safe way that plausibly improves the clinical prognosis. This technique requires close collaboration of the multidisciplinary team. Although data do not demonstrate an advantage among the different modalities of renal replacement therapy, we firmly believe that we are moving towards an evidence-based standardization of treatment, which should promote a continuous improvement in the management of critically ill patients with acute renal injury. The present study accomplishes the evolution of technology, the components of the extracorporeal circuit, the initial steps while using these dedicated machines, the principles of mechanisms of solute and water transport, and finally the most frequently prescribed modalities in CRRT.


REFERENCES

  1. Kramer P, Wigger W, Rieger J, Matthei D, Scheler F. Arteriovenous hemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr. 1977;55:1121-2.

  2. Cerda J, Sheinfeld G, Ronco C. Fluid overload in critically ill patients with acute kidney injury. Blood Purification. 2010;29:11-8.

  3. Kidney International. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138.

  4. Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Kellum JA, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif. 2016;42(3):224-37.

  5. 5 Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813-8.

  6. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units — causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. Crit Care Med. 1996; 24:192-8.

  7. Liang KV, Sileanu FE, Clermont G, Murugan R, Pike F, Palevsky P. Modality of RRT and recovery of kidney function after AKI in patients surviving to hospital discharge. Clin J Am Soc Nephrol. 2016; 11(1):30-8.

  8. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: A meta- analysis. Intensive Care Med. 2002;28:29-37.

  9. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;3:CD003773.

  10. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M; Alberta Kidney Disease Network. Renal replacement therapy in patients with acute renal failure: A systematic review. JAMA. 2008;299:793-805.

  11. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis. Crit Care Med. 2008;36:610-7.

  12. Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367:2505-14.

  13. Werner H, Herbertson M, Seear M. Operating characteristics of pediatric continuous arteriovenous hemofiltration in an animal model. Pediatr Nephrol. 1993;7(2):189-93.

  14. Prowle J, Bellomo R. Continuous renal replacement therapy: recent advances and future research. Nat Rev Nephrol. 2010;6:521-9.

  15. Villa G, Neri M, Bellomo R, Cerda J, De Gaudio R, De Rosa S, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical application. Critical Care. 2016;20:283.

  16. Clark WR, Gao D. Properties of membranes used for hemodialysis therapy. Semin Dial. 2002;15:191-5.

  17. Ronco C. Continuous renal replacement therapy: forty-year anniversary. Int J Ar f Organs. 2017;40(6):257-64.

  18. Ronco C, Neri M, Lorenzin A, F Garzotto, Clark W. Multidimensional classification of dialysis membranes. Contrib Nephrol. 2017;191:115-26.

  19. Uhlenbusch-Körwer I, Bonnie-Schorn E, Grassman A, Vienken J. Performance parameters. Understanding Membranes and Dialyzers, vol 5. Pabst Science Publishers; 2004. pp. 103-55.

  20. Macedo E, Mehta R. Continuous dialysis Therapies: Core curriculum 2016. Am J Kidney Dis. 2016;68(4):645-57.

  21. Neri M, Villa G, Garzotto F, Bagshaw S, Bellomo R, Cerda J, et al. Nomenclature for renal replacement therapy in acute kidney injury: basic principles. Critical Care. 2016;20:318.

  22. Liborio AB, Leite TT, Neves FM, Teles F, Bezerra CT. AKI complications in critically ill patients: association with mortality rates and RRT. Clin J Am Soc Nephrol. 2015;10(1):21-8.

  23. Fülöp T, Pathak MB, Schmidt DW, Lengvárszky Z, Juncos JP, Lebrun CJ, et al. Volume related weight gain and subsequent mortality in acute renal failure patients treated with continuous renal replacement therapy. ASAIO J. 2010;56(4):333-7.

  24. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259-65.

  25. Skorecki K, Chertow GM, Marsden PA, TaalMW, Yu ASL. Brenner and Rector’s The kidney. 10th ed. Philadelphia, PA: Elsevier; 2016.

  26. Cruz D, Bobek I, Lentini P, Soni S, Chionh CY, Ronco C. Machines for continuous renal replacement therapy. Semin Dial. 2009;22(2):123-32.

  27. Cruz D, de Cal M, Piccinni P, Ronco C. Polymyxin-B hemoper- fusion and endotoxin removal: lessons from a review of the literature. Contrib Nephrol. 2010;167:77-82.

  28. Ficheux A, Ronco C, Brunet P, Argiles A. El coeficiente de ultrafiltración: este viejo ‘gran inconnu’ en diálisis. Nephrol Dial Transplant. 2015;30(2):204-8.

  29. Cerda, J Baldwin I, Honore PM, Villa G, Kellum JA, Ronco C. Role of technology for the management of AKI in critically ill patients: from adoptive technology to precision continuous renal replacement therapy. Blood Purif. 2016;42:248-65.

  30. Askenazi DJ, Heung M, Connor MJ Jr, Basu RK, Cerdá J, Doi K, et al. Optimal role of the nephrologist in the Intensive Care Unit. Blood Purif. 2017;43:68-77.

  31. Ronco C. Evolución de la hemodiafiltración. Contrib Nephrol. 2007;158:9-19.

  32. Connor MJ Jr, Karakala N. Continuous renal replacement therapy: reviewing current best practice to provide high-quality extracorporeal therapy to critically ill patients. Adv Chronic Kidney Dis. 2017;24(4):213-8.

  33. Costanzo MR, Ronco C. Ultrafiltración aislada en pacientes con insuficiencia cardiaca. Curr Cardiol Rep. 2012;14(3):254-64.

  34. Ronco C, Ghezzi PM, Brendolan A, Crepaldi C, La Greca G. The haemodialysis system: basic mechanisms of water and solute transport in extracorporeal renal replacement therapies. Nephrol Dial Transplant. 1998;13(Suppl 6):3-9.




2020     |     www.medigraphic.com